Clinical effects of Goshajinkigan for overactive bladder in female patients and correlation between severity of OAB symptoms and coldness.

Clinical effects of Goshajinkigan for overactive bladder in female patients and correlation between severity of OAB symptoms and coldness. - Clinical effects of Goshajinkigan for overactive bladder in female patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009593

Enrollment

Registered

2012-12-20

Start date

2012-11-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

Goshajinnkigan 7.5g PO tid for 4 weeks

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1)Written informed consent 2)OABSS Q3 2<=, OABSS total score 3<=

Exclusion criteria

Exclusion criteria: 1)On-going Kampo-therapy 2)Neurogenic bladder 3)Previous XRT therapy for whole pevis 4)UTI 5)Any other cases who are regarded as inadequate for study enrollment by the investigator

Design outcomes

Primary

Measure	Time frame
OABSS	—

Secondary

Measure	Time frame
1)Symptom score of coldness 2)IPSS 3)Body temperature	—

Countries

Japan

Contacts

Public ContactToyohiko Watanabe

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Department of Urology

086-235-7287

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026